<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>294</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15642995</PubmedId>
            <Abstract>Recently, a novel 12-mer B-cell epitope, MKNNPIYSEGSL, in the type-specific region of equine herpesvirus 1 (EHV-1) glycoprotein G (gG) was identified and used as an antigen for enzyme-linked immunosorbent assay (Maeda et al., J. Clin. Microbiol. 42:1095-1098, 2004). Although our prototype strain, TH20p, possesses two repeat sequences containing the B-cell epitope, the EHV-4 NS80567 strain has two repeat sequences that are not identical. One repeat sequence stretch contained the B-cell epitope, while the other contained the 11-mer, MKNNPVYSESL (underlining indicates a different amino acid). In this study, heterogeneity of the type-specific region was compared among Japanese EHV-4 isolates. The 11-mer peptide, MKNNPVYSESL, specifically reacted with sera from horses naturally infected with EHV-4 but not with sera from horses experimentally infected with EHV-4 TH20p. The 11-mer peptide may be another B-cell epitope in the type-specific region.</Abstract>
            <ArticleYear>2005</ArticleYear>
            <ArticlePages>122-4</ArticlePages>
            <ArticleTitle>Identification of another B-cell epitope in the type-specific region of equine herpesvirus 4 glycoprotein G.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Maeda</LastName>
                    <ForeName>Ken</ForeName>
                </Author>
                <Author>
                    <LastName>Mizukoshi</LastName>
                    <ForeName>Fuminori</ForeName>
                </Author>
                <Author>
                    <LastName>Hamano</LastName>
                    <ForeName>Masataka</ForeName>
                </Author>
                <Author>
                    <LastName>Kai</LastName>
                    <ForeName>Kazushige</ForeName>
                </Author>
                <Author>
                    <LastName>Kondo</LastName>
                    <ForeName>Takashi</ForeName>
                </Author>
                <Author>
                    <LastName>Matsumura</LastName>
                    <ForeName>Tomio</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Veterinary Microbiology, Faculty of Agriculture, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan. kmaeda@yamaguchi-u.ac.jp.</Affiliations>
            <ArticleChemicalList>Epitopes, B-Lymphocyte;Viral Envelope Proteins;glycoprotein G, Equid herpesvirus 4</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte(immunology); Herpesviridae Infections(diagnosis; immunology; veterinary); Herpesvirus 4, Equid(immunology); Molecular Sequence Data; Polymerase Chain Reaction; Viral Envelope Proteins(genetics; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>12</Volume>
                <Issue>1</Issue>
                <Title>Clinical and diagnostic laboratory immunology.</Title>
                <Issn>1098-6588</Issn>
                <MedlineTa>Clin Diagn Lab Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Equine herpesvirus 4 glycoprotein G peptide G1</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MKNNPIYSEGSL</LinearSequence>
                        <StartingPosition>319</StartingPosition>
                        <EndingPosition>330</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>NP_045287.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10331</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Text page 122</LocationOfData>
                <EpitopeId>41866</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>148</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>10000405</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Equid herpesvirus 4</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intranasal</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Sera were collected from 6 foals that were experimentally infected with EHV-4 TH20p, which was plaque purified from strain TH20, isolated from a colt suffering from respiratory disease.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Equine herpesvirus 4 glycoprotein G peptide G1</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MKNNPIYSEGSL</LinearSequence>
                                        <StartingPosition>319</StartingPosition>
                                        <EndingPosition>330</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>NP_045287.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10331</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>149</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:934</DiseaseState>
                                <DiseaseStage>Post</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>10331</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Equid herpesvirus 4</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Field sera were collected during acute and convalescent phases from foals or yearlings with pyrexia due to EHV-4 infection.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>7</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>7</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Sera collected from horses naturally infected with EHV-4 during the convalescent phase showed higher reactivity to the epitope than sera collected during the acute phase.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Equine herpesvirus 4 glycoprotein G peptide G1</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MKNNPIYSEGSL</LinearSequence>
                                        <StartingPosition>319</StartingPosition>
                                        <EndingPosition>330</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>NP_045287.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10331</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Equine herpesvirus 4 glycoprotein G peptide G13</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MKNNPVYSESL</LinearSequence>
                        <StartingPosition>345</StartingPosition>
                        <EndingPosition>355</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>NP_045287.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10331</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Text page 122</LocationOfData>
                <EpitopeId>41868</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>1408581</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:934</DiseaseState>
                                <DiseaseStage>Post</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>10331</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Equid herpesvirus 4</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Field sera were collected during acute and convalescent phases from foals or yearlings with pyrexia due to EHV-4 infection.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>7</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>85.7</ResponseFrequency>
                            <AssayComments>Sera collected from horses naturally infected with EHV-4 during the convalescent phase showed higher reactivity to the epitope than sera collected during the acute phase.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Equine herpesvirus 4 glycoprotein G peptide G13</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MKNNPVYSESL</LinearSequence>
                                        <StartingPosition>345</StartingPosition>
                                        <EndingPosition>355</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>NP_045287.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10331</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>1408580</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9796</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>10000405</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Equid herpesvirus 4</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intranasal</Route>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Sera were collected from 6 foals that were experimentally infected with EHV-4 TH20p, which was plaque purified from strain TH20, isolated from a colt suffering from respiratory disease.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Equine herpesvirus 4 glycoprotein G peptide G13</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MKNNPVYSESL</LinearSequence>
                                        <StartingPosition>345</StartingPosition>
                                        <EndingPosition>355</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>NP_045287.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10331</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

